High-intensity interval training and moderate-intensity continuous training in adults with Crohn’s disease: a pilot randomised controlled trial

Article


Tew, Garry A., Leighton, Dean, Carpenter, R., Anderson, Simon, Langmead, Louise, Ramage, John, Faulkner, James, Coleman, Elizabeth, Fairhurst, Caroline, Seed, M. and Bottoms, Lindsay 2019. High-intensity interval training and moderate-intensity continuous training in adults with Crohn’s disease: a pilot randomised controlled trial. BMC Gastroenterology. 19, p. Art. 19. https://doi.org/10.1186/s12876-019-0936-x
AuthorsTew, Garry A., Leighton, Dean, Carpenter, R., Anderson, Simon, Langmead, Louise, Ramage, John, Faulkner, James, Coleman, Elizabeth, Fairhurst, Caroline, Seed, M. and Bottoms, Lindsay
Abstract

Background: This study assessed the feasibility and acceptability of two common types of exercise training—high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT)—in adults with Crohn’s disease (CD).

Methods: In this mixed-methods pilot trial, participants with quiescent or mildly-active CD were randomly assigned 1:1:1 to HIIT, MICT or usual care control, and followed up for 6 months. The HIIT and MICT groups were offered three exercise sessions per week for the first 12 weeks. Feasibility outcomes included rates of recruitment, retention, outcome completion, and exercise attendance. Data were collected on cardiorespiratory fitness (e.g., peak oxygen uptake), disease activity, fatigue, quality of life, adverse events, and intervention acceptability (via interviews).

Results: Over 17 months, 53 patients were assessed for eligibility and 36 (68%) were randomised (47% male; mean age 36.9 [SD 11.2] years); 13 to HIIT, 12 to MICT, and 11 to control. The exercise session attendance rate was 62% for HIIT (288/465) and 75% for MICT (320/429), with 62% of HIIT participants (8/13) and 67% of MICT participants (8/12) completing at least 24 of 36 sessions. One participant was lost to follow-up. Outcome completion rates ranged from 89 to 97%. The mean increase in peak oxygen uptake, relative to control, was greater following HIIT than MICT (2.4 vs. 0.7 mL/kg/min). There were three non-serious exercise-related adverse events, and two exercise participants experienced disease relapse during follow-up.

Conclusions: The findings support the feasibility and acceptability of the exercise programmes and trial procedures. A definitive trial is warranted. Physical exercise remains a potentially useful adjunct therapy in CD.

JournalBMC Gastroenterology
Journal citation19, p. Art. 19
ISSN1471-230X
Year2019
PublisherBMC
Accepted author manuscript
License
File Access Level
Repository staff only
Publisher's version
License
Digital Object Identifier (DOI)https://doi.org/10.1186/s12876-019-0936-x
Web address (URL)https://doi.org/10.1186/s12876-019-0936-x
Publication dates
Online29 Jan 2019
Publication process dates
Deposited22 Jan 2019
Accepted21 Jan 2019
Accepted21 Jan 2019
FunderCrohn's and Colitis UK
Crohn's and Colitis UK
External resource12876_2019_936_MOESM3_ESM.docx
12876_2019_936_MOESM2_ESM.docx
12876_2019_936_MOESM1_ESM.docx
Copyright information© 2019 The authors
LicenseCC BY 4.0
Permalink -

https://repository.uel.ac.uk/item/844xq

Download files

Publisher's version
s12876-019-0936-x.pdf
License: CC BY 4.0

  • 55
    total views
  • 82
    total downloads
  • 5
    views this month
  • 1
    downloads this month

Export as

Related outputs

Targeting Extracellular Vesicles to the Arthritic Joint using a Damaged Cartilage Specific Antibody
Topping, L. M., Thomas, B. L., Rhys, H. I., Tremoleda, J. L., Foster, M., Seed, M., Voisin, M., Vinci, C., Law, H. L., Perretti, M., Norling, L. V., Azevedo, H. S. and Nissim, A. 2020. Targeting Extracellular Vesicles to the Arthritic Joint using a Damaged Cartilage Specific Antibody. Frontiers in Immunology. 11 (Art. 10). https://doi.org/10.3389/fimmu.2020.00010
Effects of heparan sulfates with different structures on leukaemia cells: U937 and THP-1 cell differentiation
Bajwa, P., Garrido Mesa, N., Seed, M. and Ayoub, S. 2019. Effects of heparan sulfates with different structures on leukaemia cells: U937 and THP-1 cell differentiation. 14th World Congress on Inflammation 2019. Sydney, AU 15 - 19 Sep 2019 World Congress on Inflammation.
Sucrose octasulphate regulates the expression of M1 and M2 macrophage-specific markers in U937 monocytes
Bajwa, P., Garrido Mesa, N., Seed, M. and Ayoub, S. 2019. Sucrose octasulphate regulates the expression of M1 and M2 macrophage-specific markers in U937 monocytes. 14th World Congress on Inflammation 2019. Sydney, AU 15 - 19 Sep 2019 World Congress on Inflammation.
Affective and enjoyment responses to 12 weeks of high intensity interval training and moderate continuous training in adults with Crohn’s disease
Bottoms, L., Leighton, D., Carpenter, R., Anderson, S., Langmead, L., Ramage, J., Faulkner, J., Coleman, E., Fairhurst, C., Seed, M. and Tew, G. 2019. Affective and enjoyment responses to 12 weeks of high intensity interval training and moderate continuous training in adults with Crohn’s disease. PLOS ONE. 14 (Art. e0222060). https://doi.org/10.1371/journal.pone.0222060
Hydroalcoholic crude extract of Casearia sylvestris Sw. reduces chronic post-ischemic pain by activation of pro-resolving pathways
Piovezan, Anna P., Batisti, Ana P., Benevides, Maria L.A.C.S., Turnes, Bruna L., Martins, Daniel F., Kanis, Luiz, Duarte, Elisa C.W., Cavalheiro, Alberto J., Bueno, Paula C.P., Seed, M., Norling, Lucy V., Cooper, Dianne, Headland, Sarah, Souza, Patrícia R.P.S. and Perretti, Mauro 2017. Hydroalcoholic crude extract of Casearia sylvestris Sw. reduces chronic post-ischemic pain by activation of pro-resolving pathways. Journal of Ethnopharmacology. 204, pp. 179-188. https://doi.org/10.1016/j.jep.2017.03.059
Feasibility of high-intensity interval training and moderate-intensity continuous training in adults with inactive or mildly active Crohn’s disease: study protocol for a randomised controlled trial
Tew, Garry A., Carpenter, R., Seed, M., Anderson, Simon, Langmead, Louise, Fairhurst, Caroline and Bottoms, Lindsay 2017. Feasibility of high-intensity interval training and moderate-intensity continuous training in adults with inactive or mildly active Crohn’s disease: study protocol for a randomised controlled trial. Pilot and Feasibility Studies. 2017 (3:17). https://doi.org/10.1186/s40814-017-0133-z
Locomotor Muscle Fatigue Does Not Alter Oxygen Uptake Kinetics during High-Intensity Exercise
Hopker, James G., Caporaso, Giuseppe, Azzalin, Andrea, Carpenter, R. and Marcora, Samuele M. 2016. Locomotor Muscle Fatigue Does Not Alter Oxygen Uptake Kinetics during High-Intensity Exercise. Frontiers in Physiology. 7 (463). https://doi.org/10.3389/fphys.2016.00463
Applying refinement to the use of mice and rats in rheumatoid arthritis research
Hawkins, Penny, Armstrong, Rachel, Boden, Tania, Garside, Paul, Knight, Katherine, Lilley, Elliot, Seed, M., Wilkinson, Michael and Williams, Richard O. 2015. Applying refinement to the use of mice and rats in rheumatoid arthritis research. Inflammopharmacology. 23 (4), pp. 131-150.
Does this case hold the answer to one of the worse types of pain in medicine--that of loin pain haematuria syndrome (LPHS)
Russell, Alan, Chatterjee, Suman and Seed, M. 2015. Does this case hold the answer to one of the worse types of pain in medicine--that of loin pain haematuria syndrome (LPHS). BMJ Case Reports. 2015 (apr26). https://doi.org/10.1136/bcr-2014-209165
Animal models of rheumatoid arthritis: How informative are they?
McNamee, Kay, Williams, Richard and Seed, M. 2015. Animal models of rheumatoid arthritis: How informative are they? European Journal of Pharmacology. 759, pp. 278-286.
Targeting of viral interleukin-10 with an antibody fragment specific to damaged arthritic cartilage improves its therapeutic potency
Hughes, Chris, Sette, Angelica, Seed, M., D’Acquisto, Fulvio, Manzo, Antonio, Vincent, Tonia L, Lim, Ngee and Nissim, Ahuva 2014. Targeting of viral interleukin-10 with an antibody fragment specific to damaged arthritic cartilage improves its therapeutic potency. Arthritis Research & Therapy. 16 (4), p. R151.